In addition, over a decade of transcriptional and LC–MS/MS-based urine proteomic studies [48,50,58,61,62,63,64] have resulted in a deeper biological understanding of kidney injury across different causes of CKD, which drove the selection of biomarkers for inclusion in the KIT assay to represent injury across different intra-renal compartments. This evidence concerns the gene KIT and chronic kidney disease.